Status:
RECRUITING
Prospective Screening for Breast Cancer-related Lymphedema
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lymphedema
Eligibility:
FEMALE
18+ years
Brief Summary
The primary objectives of this study are twofold: 1) to detect and determine the level of symptoms, functional disability, and changes in quality of life that breast cancer patients experience from ch...
Detailed Description
The goal of the study is to create a large, prospectively maintained database with data from multiple objective measurement methods (i.e. perometry and BIS) that has detailed information on patient's ...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of breast cancer
- Ability to obtain physical positioning for perometry (e.g. abducting shoulder to 90 degrees) and BIS measurements (e.g. standing without aid)
Exclusion
- Evidence of distant metastatic disease that may cause edema,
- Previous breast cancer
- History of lymphedema
- Pregnancy at the time of accrual and/or cardiac implants (contraindications for BIS)
- Medical conditions that cause fluid retention or swelling (e.g. axillary cancer recurrence, renal insufficiency, congestive heart failure).
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT01521741
Start Date
August 1 2009
End Date
December 1 2026
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02134